This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (MTD) and Lifestance Health Group (LFST)

Tipranks - Sat May 9, 10:20AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Mettler-Toledo (MTD) and Lifestance Health Group (LFST).

Claim 55% Off TipRanks

Mettler-Toledo (MTD)

In a report released today, Evie Koslosky from Goldman Sachs maintained a Hold rating on Mettler-Toledo, with a price target of $1400.00. The company’s shares closed last Friday at $1153.34, close to its 52-week low of $1142.91.

According to TipRanks.com, Koslosky is a 1-star analyst with an average return of -5.8% and a 20.0% success rate. Koslosky covers the Healthcare sector, focusing on stocks such as Caris Life Sciences, Inc., Agilent, and Danaher. ;'>

Currently, the analyst consensus on Mettler-Toledo is a Moderate Buy with an average price target of $1444.00.

See the top stocks recommended by analysts >>

Lifestance Health Group (LFST)

UBS analyst Kevin Caliendo maintained a Buy rating on Lifestance Health Group today and set a price target of $13.00. The company’s shares closed last Friday at $7.80.

According to TipRanks.com, Caliendo is a 3-star analyst with an average return of 3.3% and a 53.4% success rate. Caliendo covers the Healthcare sector, focusing on stocks such as Solventum Corporation, Quest Diagnostics, and Accendra Health. ;'>

Currently, the analyst consensus on Lifestance Health Group is a Strong Buy with an average price target of $10.25, representing a 28.0% upside. In a report released yesterday, TipRanks – PerPlexity also upgraded the stock to Buy with a $8.50 price target.

Read More on MTD:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.